Linda Elsegood

Linda Elsegood founded the LDN Research Trust as a U.K. nonprofit registered charity in 2004, after her success with Low Dose Naltrexone (LDN).  The primary aim of the Trust is to initiate clinical trials of Low Dose Naltrexone for autoimmune diseases and cancers. She was diagnosed with multiple sclerosis (MS) in August 2000 at the age of 44, but my MS can now be traced back to when I was 32 or younger. This led her to create www.ldnresearchtrust.org. The website now features lists of clinical trials and studies involving LDN, conditions for which LDN is used, global LDN prescribers and pharmacists, prescriber/patient guides, and more. The LDN Research Trust is run purely by volunteers; we receive no funding and rely on donations, they work closely with prescribers, pharmacists, and patients, offering support and education. The website is www.ldnresearchtrust.org